Search Results - "Ivankova, Jela"

Refine Results
  1. 1

    Association of Genetic Variability in Selected Genes in Patients With Deep Vein Thrombosis and Platelet Hyperaggregability by Sokol, Juraj, Skerenova, Maria, Ivankova, Jela, Simurda, Tomas, Stasko, Jan

    Published in Clinical and applied thrombosis/hemostasis (01-10-2018)
    “…The aim of this study was to evaluate the genetic variability of the selected single nucleotide polymorphisms (SNPs) and examine the association between these…”
    Get full text
    Journal Article
  2. 2

    The Impact of Proton Pump Inhibition on Dabigatran Levels in Patients With Atrial Fibrillation by Bolek, Tomáš, Samoš, Matej, Stančiaková, Lucia, Ivanková, Jela, Škorňová, Ingrid, Staško, Ján, Galajda, Peter, Kubisz, Peter, Mokáň, Marián

    Published in American journal of therapeutics (01-05-2019)
    “…Proton pump inhibition (PPI) administrated together with dabigatran reduces the risk of gastrointestinal hemorrhage. However, there is a discussion regarding…”
    Get full text
    Journal Article
  3. 3

    First evidence: rivaroxaban and apixaban reduce thrombin-dependent platelet aggregation by Sokol, Juraj, Nehaj, Frantisek, Ivankova, Jela, Mokan, Michal, Mokan, Marian

    Published in Journal of thrombosis and thrombolysis (01-10-2018)
    “…Rivaroxaban and apixaban are direct oral anticoagulants whose target specificity is to activate factor X (FXa). It is still not fully understood how xabans…”
    Get full text
    Journal Article
  4. 4

    Edoxaban affects TRAP-dependent platelet aggregation by Nehaj, Frantisek, Sokol, Juraj, Ivankova, Jela, Mokan, Michal, Mokan, Marian, Stasko, Jan

    Published in Journal of thrombosis and thrombolysis (01-05-2020)
    “…Edoxaban is an oral anticoagulant drug and a direct factor Xa inhibitor. However, it is still not fully understood if and how edoxaban impacts platelet…”
    Get full text
    Journal Article
  5. 5

    Impact of Dabigatran Treatment on Rotation Thromboelastometry by Sokol, Juraj, Nehaj, Frantisek, Ivankova, Jela, Mokan, Michal, Zolkova, Jana, Lisa, Lenka, Linekova, Ludmila, Mokan, Marian, Stasko, Jan

    “…A rapid and reliable assessment of the dabigatran effect is desirable in dabigatran treated patients with uncontrolled bleeding or before acute surgery. The…”
    Get full text
    Journal Article
  6. 6

    Thrombin Receptor Agonist Peptide–Induced Platelet Aggregation Is Reduced in Patients Receiving Dabigatran by Nehaj, Frantisek, Sokol, Juraj, Mokan, Michal, Ivankova, Jela, Mokan, Maros

    Published in Clinical and applied thrombosis/hemostasis (01-03-2018)
    “…The availability of direct oral anticoagulants has caused a paradigm shift in thrombosis management. The direct thrombin inhibitor dabigatran seems to obstruct…”
    Get full text
    Journal Article
  7. 7

    How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved? by Stanciakova, Lucia, Dobrotova, Miroslava, Holly, Pavol, Zolkova, Jana, Vadelova, Lubica, Skornova, Ingrid, Ivankova, Jela, Samos, Matej, Bolek, Tomas, Grendar, Marian, Danko, Jan, Kubisz, Peter, Stasko, Jan

    Published in Clinical and applied thrombosis/hemostasis (01-02-2022)
    “…Low-molecular-weight heparin (LMWH) is suggested for thromboprophylaxis in pregnant women with previous venous thromboembolism (VTE). Anyway, there is only…”
    Get full text
    Journal Article
  8. 8

    Does type 2 diabetes affect the on-treatment levels of direct oral anticoagulants in patients with atrial fibrillation? by Samoš, Matej, Bolek, Tomáš, Stančiaková, Lucia, Škorňová, Ingrid, Ivanková, Jela, Kovář, František, Galajda, Peter, Kubisz, Peter, Staško, Ján, Mokáň, Marián

    Published in Diabetes research and clinical practice (01-01-2018)
    “…•This is the first study directly examining the effect of T2D on DOACs plasma levels in patients with AF.•There were no significant differences in dabigatran…”
    Get full text
    Journal Article
  9. 9

    Impact of Edoxaban on Thrombin-Dependent Platelet Aggregation by Sokol, Juraj, Nehaj, Frantisek, Ivankova, Jela, Mokan, Michal, Lisa, Lenka, Zolkova, Jana, Vadelova, Lubica, Mokan, Marian, Stasko, Jan

    “…Edoxaban, a direct factor Xa inhibitor (FXa), is the fourth direct oral anticoagulant (DOAC) approved for clinical use. As the main adverse event is bleeding,…”
    Get full text
    Journal Article
  10. 10

    Platelet miRNA Expression in Patients with Sticky Platelet Syndrome by Belakova, Kristina Maria, Zolkova, Jana, Vadelova, Lubica, Skerenova, Maria, Ivankova, Jela, Lenka, Lisa, Sokol, Juraj, Stasko, Jan

    Published in Acta Medica Martiniana (01-08-2023)
    “…Sticky platelet syndrome (SPS) is a disorder with familial occurrence and autosomal dominant trait characterized by platelet hyperaggregability in response to…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Association of Genetic Variability in Selected Genes with Platelet Hyperaggregability and Arterial Thrombosis by Brunclikova Monika, Ivankova Jela, Skerenova, Maria, Simurda Tomas, Stanciakova Lucia, Skornova Ingrid, Sterankova Miroslava, Zolkova Jana, Dobrotova Miroslava, Pavol, Holly, Kubisz, Peter, Stasko, Jan

    Published in Acta Medica Martiniana (01-04-2022)
    “…Introduction: Inherited platelet hyperaggregability, so called “Sticky platelet syndrome” (SPS), is a prothrombotic platelet disorder. The syndrome contributes…”
    Get full text
    Journal Article
  14. 14

    Monitoring of dabigatran therapy using Hemoclot® Thrombin Inhibitor assay in patients with atrial fibrillation by Samoš, Matej, Stančiaková, Lucia, Ivanková, Jela, Staško, Ján, Kovář, František, Dobrotová, Miroslava, Galajda, Peter, Kubisz, Peter, Mokáň, Marián

    Published in Journal of thrombosis and thrombolysis (01-01-2015)
    “…Dabigatran, a new direct thrombin inhibitor, achieves strong anticoagulation that is more predictable than warfarin. Nevertheless, a patient on dabigatran…”
    Get full text
    Journal Article
  15. 15

    Variability of GP6 gene in patients with sticky platelet syndrome and deep venous thrombosis and/or pulmonary embolism by Kotuličová, Daniela, Chudý, Peter, Škereňová, Mária, Ivanková, Jela, Dobrotová, Miroslava, Kubisz, Peter

    Published in Blood coagulation & fibrinolysis (01-09-2012)
    “…The GP6 gene encodes the GPVI, a crucial platelet membrane glycoprotein, for adequate platelet activation, adhesion and aggregation. The objectives of the…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Therapeutic angiogenesis improves fibrinolytic imbalance in patients with critical limb ischemia by Chudý, Peter, Chudá, Daniela, Ivanková, Jela, Šinák, Igor, Talapková, Renáta, Staško, Ján, Kubisz, Peter

    Published in Blood coagulation & fibrinolysis (01-03-2014)
    “…The mechanisms of fibrinolysis have been suggested to be linked to the pathogenesis of peripheral artery disease. The impact of therapeutic angiogenesis on the…”
    Get full text
    Journal Article
  18. 18

    The prevalence of the platelet glycoprotein VI polymorphisms in patients with sticky platelet syndrome and ischemic stroke by Kubisz, Peter, Ivanková, Jela, Škereňová, Mária, Staško, Ján, Hollý, Pavol

    Published in Hematology (Luxembourg) (01-11-2012)
    “…The aim of the study was to evaluate the genetic variability of the GP6 gene in patients with sticky platelet syndrome (SPS), a disorder characterized by…”
    Get more information
    Journal Article
  19. 19

    GP6 Haplotype of Missense Variants is Associated with Sticky Platelet Syndrome Manifested by Fetal Loss by Škereňová, Mária, Sokol, Juraj, Biringer, Kamil, Ivanková, Jela, Staško, Ján, Kubisz, Peter, Lasabová, Zora

    Published in Clinical and applied thrombosis/hemostasis (01-01-2018)
    “…Disequilibrium of hemostasis is central to the pathogenesis of all thromboses, and platelets are essential for primary hemostasis. The platelet membrane…”
    Get full text
    Journal Article
  20. 20

    Effect of Bisoprolol on the Level of Dabigatran by Nehaj, Frantisek, Sokol, Juraj, Ivankova, Jela, Mokan, Michal, Mokan, Marian

    Published in American journal of therapeutics (01-03-2020)
    “…Many patients receiving dabigatran treatment might also require bisoprolol therapy. However, there is a possibility that bisoprolol as significant…”
    Get full text
    Journal Article